Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.215 AUD
7.5%
Market Closed
Updated:
May 14, 2024
Somnomed Ltd
Research & Development
|
Somnomed Ltd
Research & Development Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Research & Development
-AU$13.3m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-18%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Research & Development
-AU$236k
|
CAGR 3-Years
52%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$3.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-57%
|
|
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$269.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Research & Development
-AU$3.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Research & Development?
Research & Development
-13.3m
AUD
-13.3m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Research & Development amounts to -13.3m AUD.
What is Somnomed Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-18%
-18%
Over the last year, the Research & Development growth was -21%. The average annual Research & Development growth rates for Somnomed Ltd have been -35% over the past three years , -19% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
